1. Wu, Xia, Cai, Hao, Qiu, Yu, Zhou, Dao-Bin, Cao, Xin-Xin. 2020. ETV6-ACSL6 fusion gene in myeloid neoplasms: clinical spectrum, current practice, and outcomes. In Orphanet journal of rare diseases, 15, 192. doi:10.1186/s13023-020-01478-6. https://pubmed.ncbi.nlm.nih.gov/32723365/
2. Di, Yuqin, Wang, Ziyang, Xiao, Jing, Wang, Xiongjun, He, Weiling. 2024. ACSL6-activated IL-18R1-NF-κB promotes IL-18-mediated tumor immune evasion and tumor progression. In Science advances, 10, eadp0719. doi:10.1126/sciadv.adp0719. https://pubmed.ncbi.nlm.nih.gov/39292786/
3. Cao, Yang, Vergnes, Laurent, Wang, Yu-Chen, Reue, Karen, Lusis, Aldons J. 2022. Sex differences in heart mitochondria regulate diastolic dysfunction. In Nature communications, 13, 3850. doi:10.1038/s41467-022-31544-5. https://pubmed.ncbi.nlm.nih.gov/35787630/
4. Quan, Jing, Bode, Ann M, Luo, Xiangjian. 2021. ACSL family: The regulatory mechanisms and therapeutic implications in cancer. In European journal of pharmacology, 909, 174397. doi:10.1016/j.ejphar.2021.174397. https://pubmed.ncbi.nlm.nih.gov/34332918/
5. Hua, Hui, Pan, Shuaikang, Diao, Haizhou, Qian, Xiaojun, Zhang, Jinguo. 2024. Increased ACSL6 Expression Predicts a Favorable Prognosis in Triple-negative Breast Cancer. In Current medicinal chemistry, , . doi:10.2174/0109298673278846231222103420. https://pubmed.ncbi.nlm.nih.gov/38310395/